5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.98▼ | 1.96▲ | 1.96▲ | 2.02▼ | 2.14▼ |
MA10 | 1.97▲ | 1.96▲ | 1.96▲ | 2.08▼ | 2.12▼ |
MA20 | 1.97▲ | 1.96▲ | 1.99▼ | 2.17▼ | 1.96▲ |
MA50 | 1.95▲ | 2.00▼ | 2.06▼ | 2.08▼ | 2.22▼ |
MA100 | 1.96▲ | 2.06▼ | 2.11▼ | 1.97▲ | 4.41▼ |
MA200 | 1.99▼ | 2.13▼ | 2.15▼ | 2.04▼ | 6.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.005▲ | 0.002▲ | -0.032▼ | 0.061▲ |
RSI | 62.895▲ | 49.741▼ | 44.741▼ | 41.460▼ | 46.356▼ |
STOCH | 88.889▲ | 49.514 | 46.343 | 15.892▼ | 56.244 |
WILL %R | 0.000▲ | -31.250 | -52.174 | -85.526▼ | -60.116 |
CCI | 69.271 | 91.131 | -0.493 | -148.462▼ | -20.993 |
Tuesday, September 02, 2025 07:29 AM
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
|
Thursday, August 14, 2025 07:24 AM
Stifel analyst Stephen Willey lowered the firm’s price target on Nkarta (NKTX) to $12 from $14 and keeps a Buy rating on the shares. The recent earnings announcement and corporate update did not ...
|
Tuesday, August 12, 2025 05:01 PM
Nkarta is a biotechnology company developing allogeneic, off-the-shelf natural killer (NK) cell therapies for immune-mediated diseases. Its business centers around engineering NK cells to target and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 1.975 | 2.00 | 1.92 | 1.975 | 737,767 |
12/09/25 | 2.05 | 2.05 | 1.96 | 1.97 | 802,900 |
11/09/25 | 2.02 | 2.08 | 2.01 | 2.07 | 434,900 |
10/09/25 | 2.07 | 2.07 | 2.00 | 2.02 | 451,400 |
09/09/25 | 2.13 | 2.13 | 2.035 | 2.07 | 542,800 |
08/09/25 | 2.27 | 2.28 | 2.06 | 2.12 | 1,093,118 |
05/09/25 | 2.13 | 2.26 | 2.12 | 2.26 | 436,900 |
04/09/25 | 2.09 | 2.15 | 2.035 | 2.13 | 374,292 |
03/09/25 | 2.10 | 2.18 | 2.075 | 2.10 | 422,708 |
02/09/25 | 2.15 | 2.17 | 2.085 | 2.10 | 363,709 |
|
|
||||
|
|
||||
|
|